MET and cancer: An intragenic L1-ASP has been shown to act as an alternate promoter in cancer driving the transcription of a truncated and oncogenic isoform of the c-MET gene (28,30,61), and the ability of retrotransposons to act as alternative promoters for protein coding genes has been reported (20).